In one study, CEA proteins purified from human colon carcinoma and human liver metastases of colorectal carcinoma cells were characterized with 893 different N-glycopeptides and 128 unique N-glycan compositions identified from 21 out of 28 potential N-glycosylation sites. This evidence concerns the gene CEACAM5 and colorectal carcinoma.